Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-98-002695
Filing Date
1998-03-31
Accepted
1998-03-31 00:00:00
Documents
5
Period of Report
1997-12-31
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR FISCAL YEAR END DECEMBER 31, 1997 10-K 314052
2 STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS EX-11.1 4330
3 CONSENT OF ARTHUR ANDERSEN LLP EX-23.1 480
4 FINANCIAL DATA SCHEDULE EX-27.1 2369
5 FINANCIAL STATEMENTS OF L&I PARTNERS, L.P. EX-99.1 17573
  Complete submission text file 0000950134-98-002695.txt   340718
Mailing Address 14785 OMICRON DR SUITE 101 SAN ANTONIO TX 78245
Business Address 11550 IH-10 WEST SUITE 300 SAN ANTONIO TX 78230 2106776080
ILEX ONCOLOGY INC (Filer) CIK: 0001001915 (see all company filings)

EIN.: 742699185 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22147 | Film No.: 98580140
SIC: 8071 Services-Medical Laboratories